Laura Shawver sold $2.7M of ARS Pharmaceuticals (SPRY)

Executed Dec 2 2024, disclosed Dec 4 2024, 2 days later.

Value, as filed

$2.7M

199,099 sh across 3 lots

Executed

Dec 2 2024

the trade date, as filed

Disclosed

Dec 4 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

LS Laura Shawver Director profile →

Laura Shawver (Director) filed 5 Form 4 reports in the past 24 months (0 purchases, 5 sales), most often in SPRY. The largest single filing was $2.7M of SPRY (199,099 sh across 3 lots, as filed), executed Dec 2 2024.

The name

SPRY SPRY SPRY · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Laura Shawver in SPRY

SPRYSALE ARS Pharmaceuticals, Inc. $615K
50,002 sh × $12.30
Exec Apr 7 2025
Filed Apr 8 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $556K
49,600 sh × $11.21
Exec Mar 6 2025
Filed Mar 7 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $616K
50,000 sh × $12.31
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $555K
50,000 sh × $11.10
Exec Jan 6 2025
Filed Jan 7 2025 · 5:30 PM ET